<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE329nnn/GSE329545/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Homo sapiens</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE329545</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>Mechanisms of Differential Signaling by IFNLR1 Variants</name><description>Introduction: Lambda interferons signal through the interferon lambda receptor-1 (IFNLR1) and IL10RB heterodimer to induce interferon stimulated genes (ISGs). We previously showed that proteins derived from distinct IFNLR1 splice isoforms uniquely influence gene expression and HBV replication in stem cell-derived hepatocytes (iHeps). Here, we evaluated the mechanisms of signal transduction by full-length IFNLR1 (variant 1) and a truncated variant missing part of the cytoplasmic JAK1-interacting domain (variant 2). Methods: We evaluated HEK293T cells, wild-type (WT), and IFNLR1 knock-out (KO) iHeps with doxycycline-inducible expression FLAG-tagged IFNLR1 variants using the Duolink proximity ligation assay, ImageStream flow cytometry, western blotting of JAK-STAT proteins, susceptibility to JAK1 and TYK2 inhibitors, and gene expression profiling. Results: Each variant demonstrated IFNL-induced colocalization with IL10RB, but variant 1 was more rapidly and extensively internalized. In WT iHeps with intact endogenous IFNLR1, overexpression of either variant 1 or variant 2 enabled higher IFNL-induced JAK1, TYK2, STAT1 and STAT2 phosphorylation, yet variant 2 supported less robust ISG induction than variant 1. In iHeps with abrogated endogenous IFNLR1 expression, variant 2 supported less JAK1 and TYK2 phosphorylation and ISG induction than variant 1 yet was not deficient in supporting STAT1 and STAT2 phosphorylation. Select ISGs had differential constitutive expression in IFNL-untreated variant-expressing iHeps. In iHeps expressing variant 1, WT-iHeps were more resistant than KO-iHeps to TYK2-inhibition of antiviral ISG induction yet conversely were more susceptible to TYK2-inhibition of proinflammatory ISG induction, suggesting endogenously produced noncanonical variants influence the TYK2-dependence of IFNL signaling. Conclusions: IFNLR1 variants promote differential utilization of signaling mediators to influence IFNL-induced gene expression patterns, indicating a putative role in pathway regulation.</description><dates><publication>2026/04/30</publication></dates><accession>GSE329545</accession><cross_references><GSM>GSM9706191</GSM><GSM>GSM9706192</GSM><GSM>GSM9706193</GSM><GSM>GSM9706194</GSM><GSM>GSM9706190</GSM><GSM>GSM9706210</GSM><GSM>GSM9706199</GSM><GSM>GSM9706211</GSM><GSM>GSM9706212</GSM><GSM>GSM9706213</GSM><GSM>GSM9706195</GSM><GSM>GSM9706196</GSM><GSM>GSM9706197</GSM><GSM>GSM9706198</GSM><GSM>GSM9706218</GSM><GSM>GSM9706219</GSM><GSM>GSM9706214</GSM><GSM>GSM9706215</GSM><GSM>GSM9706216</GSM><GSM>GSM9706217</GSM><GSM>GSM9706181</GSM><GSM>GSM9706182</GSM><GSM>GSM9706183</GSM><GSM>GSM9706188</GSM><GSM>GSM9706221</GSM><GSM>GSM9706222</GSM><GSM>GSM9706200</GSM><GSM>GSM9706189</GSM><GSM>GSM9706223</GSM><GSM>GSM9706201</GSM><GSM>GSM9706202</GSM><GSM>GSM9706224</GSM><GSM>GSM9706184</GSM><GSM>GSM9706185</GSM><GSM>GSM9706186</GSM><GSM>GSM9706187</GSM><GSM>GSM9706220</GSM><GSM>GSM9706207</GSM><GSM>GSM9706208</GSM><GSM>GSM9706209</GSM><GSM>GSM9706225</GSM><GSM>GSM9706203</GSM><GSM>GSM9706226</GSM><GSM>GSM9706204</GSM><GSM>GSM9706227</GSM><GSM>GSM9706205</GSM><GSM>GSM9706228</GSM><GSM>GSM9706206</GSM><GPL>34284</GPL><GSE>329545</GSE><taxon>Homo sapiens</taxon></cross_references></HashMap>